spotlight-test1 – HKIB

Committed to GMP Since 1988

Committed to GMP Since 1988

Spotlight

If we truly nurture this platform and understand its potential, it can transform not just healthcare, but the future of biomedical innovation in Hong Kong.

Hong Kong's inclusion in PIC/S acts as a passport to major global markets, ensuring products meet high standards and can be recognized and accepted internationally

It is a very exciting time for Hong Kong and this new ATP GMP site is part of that. We want to bring innovative therapy production here and this is not just great for Hong Kong but for patients that require these therapies